D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $34 Price Target
NRX Pharmaceuticals, Inc. -0.40% Post
NRX Pharmaceuticals, Inc. NRXP | 2.51 2.53 | -0.40% +0.80% Post |
D. Boral Capital analyst Jason Kolbert maintains NRX Pharmaceuticals (NASDAQ:
NRXP) with a Buy and maintains $34 price target.
